I have had a quick look at the results. For me, the highlights were
1. Sales margins have remained the same at about 40% (from the cash flow stmt)
2. COGS was flat - considering that there was a 12% increase in sales - that is amazing.
3. Cash flow from operations increased by 26%
4. Sales grew by 12%, but NOPAT grew by 35%
5. BUT THE BIG ONE is that Seqirus made an EBIT of $184.5m for the half
A Good result.
HT1
- Forums
- ASX - By Stock
- Ann: Half Year Results Analyst Presentation
I have had a quick look at the results. For me, the highlights...
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B |
Open | High | Low | Value | Volume |
$280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1140 | $277.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$277.08 | 312 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 465 | 277.000 |
2 | 183 | 276.500 |
1 | 15 | 276.450 |
1 | 84 | 276.150 |
5 | 168 | 276.000 |
Price($) | Vol. | No. |
---|---|---|
277.490 | 340 | 1 |
277.500 | 500 | 1 |
277.570 | 6 | 1 |
277.850 | 200 | 1 |
278.000 | 50 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online